金艳霞 (1989.09)
博士 硕士生导师 楚天学子 香江学者
办公室:最信任的十大网赌网站排行榜8408室
E-mail:jinyanxia@hbnu.edu.cn
个人简历
■教育经历
2019-2020年,武汉大学/香港浸会大学 中医药学院,博士后,香江学者
2016-2018年,武汉大学 中南医院 血液科,博士后
2011-2016年,武汉大学 最信任的十大网赌网站排行榜 生物化学与分子生物学专业,理学博士
2007-2011年,湖北师范学院 最信任的十大网赌网站排行榜 生物科专业,理学学士
■工作经历
2018-至今,澳门十大赌博正规 最信任的十大网赌网站排行榜 任教
2020.08-2021.07,黄石市服务产业专才支持计划,湖北器长光电股份有限公司,企业技术顾问
2021年入选湖北省“楚天学者计划”,楚天学子
研究领域
主要从事肿瘤诊断及治疗方面的科研工作。具体研究领域包括:
■非小细胞肺癌早诊标志物筛选;蛋白糖基化修饰鉴定及与肿瘤发生的关系
■抗肿瘤药物筛选
主要社会兼职
湖北省临床肿瘤学会(ESCO)免疫治疗专家委员会,委员
湖北省细胞生物学会,会员
承担的课程
本科生:细胞生物学,生物化学及分子生物学实验
主持或参加的课题项目
■茶树菇凝集素AANL6修饰的纳米硒复合物的制备及其活性探究(湖北省重点实验室开放基金,No.EWPL202002,2021-2022,在研,主持)
■早期非小细胞肺癌中α-1-抗胰凝乳蛋白酶的GlcNAc修饰结构鉴定和其功能研究(国家自然科学基金青年项目,No.320000908,2021-2023,在研,主持)
■AACT的GlcNAc修饰位点鉴定及其在非小细胞肺癌早期发生中的生物学作用探究(湖北省自然科学青年项目,No.2020CFB417,2020-2022,在研,主持)
■新型GlcNAc修饰的AACT作为NSCLC早期诊断标志物的功能探究(澳门十大赌博正规2018年引进人才科研启动基金,No. HS2019RC008,2019-2021,结题,主持)
■澳门十大赌博正规教学改革研究项目(重点指导类),新形势下生物化学实验课程教学改革的探索与实践,(2020/10-2022/10,在研,主持)
■探究植物药物CKI激活免疫抗氧化治疗AML的作用机制(湖北省重点实验室开放基金,No.EWPL201801,2019-2020,结题,主持)
■运用凝集素亲和-质谱技术筛选多发性骨髓瘤预后监控指标(武汉大学中南医院科研创新培育基金青年项目,2016-2018,结题,主持)
■基于ROS信号通路探索壬二酸治疗急性髓系白血病的作用机制(国家自然科学基金面上项目,2018-2021,主要参加者)
代表性成果
期刊论文
■Yanxia Jin#, Yuxing Liang, Yanting Su, Lingyun Hui, Hailing Liu, Lu Ding, Fuling Zhou*, Identification of novel combined biomarkers in the diagnosis of multiple myeloma, Hematology, 2021, 26(1): 964-969.
■Yanxia Jin#, Liqin Cai#, Qian Yang, Ziyi Luo, Li Liang, Yuxing Liang, Balu Wu, Lu Ding, Dongdong Zhang, Xiaojuan Xu, Lina Zhang*, Fuling Zhou*, Anti-leukemia activities of selenium nanoparticles embedded in nanotube consisted of triple-helix β-D-glucan, Carbohydrate Polymers, 2020, 240: 116329. doi: 10.1016/j.carbpol.2020.116329.
■Yanxia Jin, Yufeng Shang, Hailing Liu, Lu Ding, Xiqin Tong, Honglei Tu, Guolin Yuan, Fuling Zhou*, A retrospective analysis: a novel index predicts survival and risk-stratification for bone destruction in 419 newly diagnosed multiple myelomas, OncoTargets and Therapy, 2019, 2019:12 10587–10596
■金艳霞,王卫东*,刘娜,张新潮,汪劲松,邱昌恩,肺癌早期诊断标志物鉴定研究进展,2019,生命的化学,39(6):1082-1089
■Yanxia Jin, Yajun Yang, Yanting Su, Xiangdong Ye, Wei Liu, Qing Yang, Jie Wang, Xiangning Fu, Yongsheng Gong*, Hui Sun*, Identification of a novel diagnostic biomarker of human early non-small cell lung cancer, Glycoconjugate Journal, 2019, 36(1): 57-68
■Yanxia Jin, Qian Yang, Li Liang, Lu Ding, Yuxing Liang, Dongdong Zhang, Balu Wu, Tian Yang, Hailing Liu, Tingting Huang, Hui Shen, Honglei Tu, Yunbao Pan, Yongchang Wei, Yi Yang, Fuling Zhou*, Compound kushen injection suppresses human acute myeloid leukaemia by regulating the Prdxs/ROS/Trx1 signalling pathway, Journal of Experimental & Clinical Cancer Research, 2018, 37: 277
■Yanxia Jin, Shishang Guo, Qin Cui, Sichao Chen, Xiaoping Liu, Yongchang Wei, Yunbao Pan, Liang Tang, Tingting Huang, Hui Shen, Guanghui Xu, Xuelan Zuo, Shangqin Liu, Hui Xiao, Fei Chen, Fayun Gong*, Fuling Zhou*, A hospital based retrospective study of factors influencing therapeutic leukapheresis in patients presenting with hyperleukocytic leukemia, Scientific reports, 2018, 8: 294
■Chenyang Lu#, Shan Meng#, Yanxia Jin#, Wanggang Zhang, Zongfang Li, Fang Wang, Feng Wang-Johanning, Yongchang Wei, Hailing Liu, Honglei Tu, Dan Su, Aili He, Xingmei Cao, Fuling Zhou*, A novel multi-epitope vaccine from MMSA-1 and DKK1 for multiple myeloma immunotherapy, Br J Haemat, 2017, 178(3): 413-426
■Yanxia Jin, Jie Wang, Xiangdong Ye, Yanting Su, Guojun Yu, Qing Yang, Wei Liu, Wenhui Yu, Jie Cai, Xi Chen, Yi Liang, Yijie Chen, Barry Hon Cheung Wong, Xiangning Fu*, Hui Sun*, Identification of GlcNAcylated Alpha-1-antichymotrypsin as an early biomarker in human non-small cell lung cancer by quantitative proteomic analysis with two lectins, Br J Cancer, 2016, 114(5): 532-544
■Yanxia Jin, Tao Che, Yalin Yin, Guojun Yu, Qing Yang, Wei Liu, Xiangdong Ye, Wenhui Yu, Shrestha Alok, Yijie Chen, Barry Hon Cheung Wong, Pengfei Cheng, Hui Sun*, Lethal protein in mass consumption edible mushroom Agrocybe aegerita linked to strong hepatic toxicity, Toxicon, 2014, 90C: 273-285
■Pan Liu, Yanxia Jin, Haseeb Sattar, Hailing Liu, Weiling Xie, Fuling Zhou*, Natural killer cell immunotherapy against multiple myeloma: progress and possibilities, J Leukocyte Biol, 2018, 103(5):821-828
■Li Liang, Yanxia Jin, Xiaoqiang Zhu, Fuling Zhou, Yi Yang*, Real-time detection and monitoring of the drug resistance of single myeloid leukemia cells by diffused total internal reflection. Lab Chip, 2018, 18: 1422-1429
会议报告及论文
■Yanxia Jin, Qiyun Wang, Yueyang Zhang, Antitumor effect of overexpressed alpha-1-antichymotrypsin on lung cancer,2021年中国肿瘤标志物学术大会(Poster)
■金艳霞,α-1-酸性糖蛋白1在肺癌中的表达、临床意义及其生物学功能探究,2021年中国肿瘤学大会(Poster)
■2020年心胸外科省级继续教育学习班-肺结节、早期肺癌MDT门诊及微创治疗,会议讲座报告《早期非小细胞肺癌肿瘤标志物的筛选》,江苏苏州,2020.10.31
■金艳霞,董婧珂,王卫东*,基于生物信息学分析探讨CD59在肺癌中的表达及其临床意义(ID:1878826),2020中国肿瘤标志物学术大会(Poster Accept)
■Yanxia Jin, Hui Sun, Identification of a novel diagnostic biomarker of human early non-small cell lung cancer (ID: 1878829),2020中国肿瘤标志物学术大会(Poster Accept)
■Yanxia Jin, Yanling Chen, Yujia Zheng, Fuling Zhou, Construction of a Novel CD34+ Hematopoietic Stem Cell Derived Xenograft Model of Human Hyperleukocytic Acute Myeloid Leukemia. Blood 2020; 136 (Supplement 1): 23–24. doi: https://doi.org/10.1182/blood-2020-141738. 62nd ASH Annual Meeting and Exposition.
■Yanxia Jin, Yuxing Liang, Lu Ding, Fuling Zhou, Identification of a novel clinical biomarker in diagnosis of multiple myeloma with quantitative proteomics by lectin AANL6. 2020中华医学会第16次全国血液学学术会议(Poster Accept)
■Yanxia Jin#, Liqin Cai#, Qian Yang, Ziyi Luo, Lina Zhang*, Fuling Zhou*, Anti-leukemia activities of selenium nanoparticles embedded in nanotube consisted of triple-helix β-D-glucan. 2020, AACR Virtual Annual Meeting II (Poster Accept)
■Yanxia Jin, Yuxing Liang, Xiqin Tong, Balu Wu, Lu Ding, Fuling Zhou*, Construction of novel patient derived xenograft model in hyperleukocytic acute myeloid leukemia. 2019, the Global Academic Programs. (Poster Accept)
■Yanxia Jin, Qian Yang, Li Liang, Lu Ding, Yuxing Liang, Dongdong Zhang, Tian Yang, Mingfeng Zhao and Fuling Zhou*, A potential mechanism for the antioxidant compound kushen injection targeting the ROS signaling pathway in acute myeloid leukemia. 2018, The American Society of Hematology, ASH, Blood, 2018, 132(suppl 1):5221.
■Yanxia Jin, Qian Yang, Dongdong Zhang, Lu Ding, Tian Yang, Balu Wu, Fuling Zhou*, The antioxidant compound kushen injection inhibit the acute myeloid leukemia proliferation via the ROS-immune pathway获2018年度湖北省医学生物免疫学会第三届年会优秀学术论文
■Yanxia Jin, Guolin Yuan, Fuling Zhou*, Innovative discovery of therapeutic plateletpheresis in patients with thrombocytosis using the Fresenius COM.TEC, Proceedings of the American Association for Cancer Research Annual Meeting 2018, AACR, Cancer Research, 2018, 78(suppl 13), pp.1645
■Yanxia Jin, Hailing Liu, Lu Ding, Xiqin Tong, Honglei Tu, Pan Liu, Yongchang Wei, Yunbao Pan, Anling Li, Shan Meng, Bo Lei, Guolin Yuan, Xuelan Zuo, Fuling Zhou*, A retrospective study of bone destruction in 419 newly diagosed multiple myeloma: correlation, a novel index predicts survival and risk-stratification,2017第十六届全国实验血液学学术会议(Poster Accept)
获奖情况
■2018年“香江学者计划”入选者,获得“香江学者奖”
■2020年湖北省细胞生物学学会青年教师讲课比赛二等奖
■2021年中国细胞生物学学会青年教师讲课比赛二等奖
■2021年澳门十大赌博正规青年教师讲课比赛校级一等奖
■指导学生获全国大学生生命科学创新创业大赛指导教师一等奖(创业类)1项和三等奖(创新类)2项
■指导学生获批大学生创新创业训练计划项目(创新训练)4项(国家级1项;湖北省级2项)
■指导学生获中国国际“互联网+”大学生创新创业大赛澳门十大赌博正规校级金奖1项,银奖1项
■2020年指导学生获第六届中国国际“互联网+”大学生创新创业大赛湖北省复赛银奖
■2021年指导学生获澳门十大赌博正规第十一届全国大学生电子商务“创新、创意及创业”挑战赛校级二等奖
■2021年指导学生获湖北省第十三届挑战杯大学生课外学术科技作品竞赛自然科学类学术论文校级三等奖
■2021年指导学生获湖北省第八届大学生生物实验技能竞赛单项赛省级三等奖
■2021年指导学生获校级优秀学士学位论文1篇